We are committed to supporting and developing initiatives that will help improve outcomes and experiences for men, whether that’s through raising awareness among groups at high risk, funding nurses to lead service improvements in their areas, or carrying out research and development to meet men’s needs in survivorship.
Showing 14 results
TrueNTH is a global initiative, led by the Movember Foundation, tackling critical areas of prostate cancer care.
Black men have a greater risk of developing prostate cancer. Here's how we're addressing it.
Find out about our work advocating that all men with prostate cancer should have access to a CNS, and how you can get involved.
We want every man with prostate cancer – or at risk of it - to have access to the same high-quality diagnosis, treatment and care.
Building on the work of the National Cancer Survivorship Institute, we funded 59 health professionals based in the NHS and other health organisations to test new or innovative models of care to support men living with and beyond prostate cancer.
We'll be surveying 100,000 men across the UK over the next three years as part of a PROMS project to identify the outcomes of diagnosis and treatment.
Here's our new consensus guidance for primary care on the use of the PSA test in men without symptoms.
During June and July 2014, we surveyed the specialist nursing workforce caring for men with prostate cancer across the UK. Here's what we found.
We wanted to make sure that information on these common, debilitating conditions was available to health professionals, so we produced guidelines.
In January 2014, we commissioned some qualitative research to find out more about the types of wellbeing services that are available to men with prostate cancer. Here's what we found.
We want all men to get access to the best ED treatment and support after prostate cancer treatment regardless of where they live in the UK.
Our study of the public’s knowledge of, awareness of and attitudes towards health, prostate cancer and Prostate Cancer UK.
We've been examining the number of prostate/urology site-specialist therapeutic radiographers in the UK, and here's what we've found.
We believe mpMRI before biopsy offers the potential for a step-change in prostate cancer diagnosis, and we’re working to support its roll-out.